Company Filing History:
1 out of 1,588 
1 out of 832,912 Years Active: 1998-2003
Title: Kunihito Watanabe: Innovator in Elastase Inhibitory Polypeptides
Introduction
Kunihito Watanabe is a notable inventor based in Hino, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of elastase inhibitory polypeptides. With a total of 2 patents to his name, Watanabe's work has the potential to impact various medical applications.
Latest Patents
Watanabe's latest patents include innovations related to benzofurylpyrone derivatives. One of his key inventions is an elastase inhibitory polypeptide that comprises a C-terminal half of a human secretory leukocyte protease inhibitor (SLPI). This polypeptide exhibits elastase inhibitory activity, where the inhibitory activity of a trypsin-like serine protease does not exceed 1/10 of the elastase inhibitory activity. Additionally, his invention encompasses polypeptides that maintain the aforementioned biological activity, even when one or more amino acids are added, deleted, or replaced. The process for producing this protein or other proteins via a corresponding fused protein is also part of his innovative contributions.
Career Highlights
Throughout his career, Watanabe has worked with prominent companies, including Teijin Limited. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in his field.
Collaborations
Watanabe has collaborated with esteemed colleagues such as Akiko Takeuchi and Takashi Sugiyama. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.
Conclusion
Kunihito Watanabe's work in elastase inhibitory polypeptides showcases his dedication to advancing biochemistry. His patents reflect a commitment to innovation that may lead to important medical breakthroughs.